These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 37175783)

  • 21. Antidiabetic efficacy of Trifolium alexandrinum extracts hesperetin and quercetin in ameliorating carbohydrate metabolism and activating IR and AMPK signaling in the pancreatic tissues of diabetic rats.
    Abdou HM; Hamaad FA; Ali EY; Ghoneum MH
    Biomed Pharmacother; 2022 May; 149():112838. PubMed ID: 35344738
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification of curcumin as a potential α-glucosidase and dipeptidyl-peptidase 4 inhibitor: Molecular docking study, in vitro and in vivo biological evaluation.
    Cao W; Chen X; Chin Y; Zheng J; Lim PE; Xue C; Tang Q
    J Food Biochem; 2022 Mar; 46(3):e13686. PubMed ID: 33817806
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Curcumin and quercetin synergistically inhibit cancer cell proliferation in multiple cancer cells and modulate Wnt/β-catenin signaling and apoptotic pathways in A375 cells.
    Srivastava NS; Srivastava RAK
    Phytomedicine; 2019 Jan; 52():117-128. PubMed ID: 30599890
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Curcumin and Type 2 Diabetes Mellitus: Prevention and Treatment.
    Pivari F; Mingione A; Brasacchio C; Soldati L
    Nutrients; 2019 Aug; 11(8):. PubMed ID: 31398884
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synthetic (+)-antroquinonol exhibits dual actions against insulin resistance by triggering AMP kinase and inhibiting dipeptidyl peptidase IV activities.
    Hsu CY; Sulake RS; Huang PK; Shih HY; Sie HW; Lai YK; Chen C; Weng CF
    Br J Pharmacol; 2015 Jan; 172(1):38-49. PubMed ID: 24977411
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A Comprehensive Review on Pharmacotherapeutics of Three Phytochemicals, Curcumin, Quercetin, and Allicin, in the Treatment of Gastric Cancer.
    Haghi A; Azimi H; Rahimi R
    J Gastrointest Cancer; 2017 Dec; 48(4):314-320. PubMed ID: 28828709
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Oral formulation of DPP-4 inhibitor plus Quercetin improves metabolic homeostasis in type 1 diabetic rats.
    Miranda PHA; Lacerda KCD; Araújo CM; Barichello JM; Lima WG; Costa DC
    Sci Rep; 2018 Oct; 8(1):15310. PubMed ID: 30333575
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dietary phytophenols curcumin, naringenin and apigenin reduce infection-induced inflammatory and contractile pathways in human placenta, foetal membranes and myometrium.
    Lim R; Barker G; Wall CA; Lappas M
    Mol Hum Reprod; 2013 Jul; 19(7):451-62. PubMed ID: 23475986
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Design, synthesis and anti-diabetic activity of triazolotriazine derivatives as dipeptidyl peptidase-4 (DPP-4) inhibitors.
    Patel BD; Bhadada SV; Ghate MD
    Bioorg Chem; 2017 Jun; 72():345-358. PubMed ID: 28302310
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Type 1 Diabetes Prevention in NOD Mice by Targeting DPPIV/CD26 Is Associated with Changes in CD8⁺T Effector Memory Subset.
    Alonso N; Julián MT; Carrascal J; Colobran R; Pujol-Autonell I; Rodriguez-Fernández S; Teniente A; Fernández MA; Miñarro A; Ruiz de Villa MC; Vives-Pi M; Puig-Domingo M
    PLoS One; 2015; 10(11):e0142186. PubMed ID: 26555789
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Combination therapy of dipeptidyl peptidase-4 inhibitors and metformin in type 2 diabetes: rationale and evidence.
    Liu Y; Hong T
    Diabetes Obes Metab; 2014 Feb; 16(2):111-7. PubMed ID: 23668534
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neuroprotective properties of the natural phenolic antioxidants curcumin and naringenin but not quercetin and fisetin in a 6-OHDA model of Parkinson's disease.
    Zbarsky V; Datla KP; Parkar S; Rai DK; Aruoma OI; Dexter DT
    Free Radic Res; 2005 Oct; 39(10):1119-25. PubMed ID: 16298737
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Combined administration of naringenin and hesperetin with optimal ratio maximizes the anti-cancer effect in human pancreatic cancer via down regulation of FAK and p38 signaling pathway.
    Lee J; Kim DH; Kim JH
    Phytomedicine; 2019 May; 58():152762. PubMed ID: 31005717
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cellular Senescence in Diabetes Mellitus: Distinct Senotherapeutic Strategies for Adipose Tissue and Pancreatic β Cells.
    Murakami T; Inagaki N; Kondoh H
    Front Endocrinol (Lausanne); 2022; 13():869414. PubMed ID: 35432205
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Improved glucose tolerance with DPPIV inhibition requires β-cell SENP1 amplification of glucose-stimulated insulin secretion.
    Ferdaoussi M; Smith N; Lin H; Bautista A; Spigelman AF; Lyon J; Dai X; Manning Fox JE; MacDonald PE
    Physiol Rep; 2020 Apr; 8(8):e14420. PubMed ID: 32339440
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dipeptidyl peptidase-4 inhibitor sitagliptin improves pancreatic β-cell function in hypertensive diabetic patients treated with angiotensin receptor blockers.
    Fukui K; Kawahito H; Wakana N; Kikai M; Terada K; Yamamoto K; Irie D; Kato T; Miyagawa S; Yamada H
    J Renin Angiotensin Aldosterone Syst; 2015 Dec; 16(4):1001-9. PubMed ID: 26195265
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of exogenous flavonoids on nodulation of pea (Pisum sativum L.).
    Novák K; Chovanec P; Skrdleta V; Kropácová M; Lisá L; Nemcová M
    J Exp Bot; 2002 Aug; 53(375):1735-45. PubMed ID: 12147723
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Anti-Diabetic, Anti-Inflammatory, and Anti-Oxidant Effects of Naringenin in an In Vitro Human Model and an In Vivo Murine Model of Gestational Diabetes Mellitus.
    Nguyen-Ngo C; Willcox JC; Lappas M
    Mol Nutr Food Res; 2019 Oct; 63(19):e1900224. PubMed ID: 31343820
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Assessment of pancreatic β-cell function: review of methods and clinical applications.
    Cersosimo E; Solis-Herrera C; Trautmann ME; Malloy J; Triplitt CL
    Curr Diabetes Rev; 2014 Jan; 10(1):2-42. PubMed ID: 24524730
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of neprilysin and neprilysin inhibitors on glucose homeostasis: Controversial points and a promising arena.
    AlAnazi FH; Al-Kuraishy HM; Al-Gareeb AI; Alexiou A; Papadakis M; Ogaly HA; Alanazi YA; Saad HM; Batiha GE
    J Diabetes; 2023 May; 15(5):397-408. PubMed ID: 37078106
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.